Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biotricity Inc (NQ: BTCY )

0.4631 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biotricity Inc

< Previous 1 2 3 4 5 6 7 8 Next >
Biotricity Launches Cardiac Application For Samsung's Watch4 Series
Biotricity Inc (NASDAQ:BTCY) announced the upcom... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Nanobiotix (NASDAQ:NBTX) shares rose 13.2% to $12.0 during Thursday's regular session. The market value of their outstanding shares is at $417.9 million.... 
Via Benzinga
Biotricity Launches Biocare Cardiac Application for Samsung's Galaxy Watch4 Series
REDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Biotricity Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the upcoming release of Biocare Cardiac... 
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Product Safety Regulatory
Remote Medical Diagnostic Company, Biotricity, to Ring the Nasdaq Stock Market Opening Bell on Thursday, October 7th
Founder and CEO Waqaas Al Siddiq and Members of Biotricity Management Team to Attend Opening Bell Ceremony on Thursday, October 7, 2021 at 9:30am E.T. REDWOOD CITY, CA / ACCESSWIRE / October 6, 2021 /... 
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Benzinga Announces The 8 'Rising Star' Companies Being Featured On Its Next 'All Access' Show
Benzinga is thrilled to announce the guest lineup for our next All Access show, set to air Thursday, October 7 at 9:00 am ET. Thursday's Guest Lineup The theme... 
Via Benzinga
Biotricity to Discuss its 2022 Strategic Outlook and Product Pipeline, at Benzinga Healthcare Small Cap Conference on Sept. 30
REDWOOD CITY, CA / ACCESSWIRE / September 28, 2021 / Biotricity Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that its Chief Executive Officer... 
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Biotricity to Discuss Expansion of Remote Monitoring Medical Device Products at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 22nd
Biokit is the Expansion of the Company's Bioflux Cardiac-Diagnostic Offering Kits on Track for Launch in Early 2022 REDWOOD CITY, CA / ACCESSWIRE / September 21, 2021 / Biotricity Inc. (NASDAQ:BTCY), a... 
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Biotricity Continues to Transform the Way We Do Health: Medtech Launches New Biokit Solution, Aims at Personal Health Monitoring
Biotricity (NASDAQ: BTCY) is reforming the healthcare market as one of the fastest-growing companies in medtech. The company bridges the gap in remote cardiac monitoring,... 
Via Benzinga
Biotricity Unveils "Biokit" with 3 Personal Medical Devices to Expand into Cardiac Disease Management
Company Expects New Personal Medical Device Kit to be available to customer by early 2022 REDWOOD CITY, CA / ACCESSWIRE / September 14, 2021 / Biotricity Inc. (NASDAQ:BTCY), a medical diagnostic and... 
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Product Safety Regulatory
Biotricity Announces Closing of Exercise of Underwriter's Option to Purchase Additional Common Stock
Underwritten Public Offering of Common Stock Resulted in Total Gross Proceeds of $16 Million REDWOOD CITY, CA / ACCESSWIRE / September 13, 2021 / Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic... 
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Biotricity to Discuss Sales Expansion, Recent Financing, and Wearable Medical Device Portfolio Expansion at H.C. Wainwright Conference
Company's Momentum Continuing with Sales Growth, Recent Nasdaq listing and Successful Equity Raise REDWOOD CITY, CA / ACCESSWIRE / September 8, 2021 / Biotricity, Inc. (NASDAQ:BTCY) ("Biotricity" or... 
From Biotricity, Inc.
Via AccessWire
Biotricity Reports Q1 Earnings at 290% for FY2022
Biotricity (NASDAQ: BTCY) has been taking the world of medtech by storm, introducing primary care providers across the country to its remote heart monitoring devices. Always... 
Via Benzinga
Biotricity Uplists to Nasdaq, Poses Significant Buying Opportunity for Investors
Image via Biotricity.com Thursday, August 26, 2021, Biotricity, Inc. (NASDAQ: BTCY) uplisted to Nasdaq after raising $15 million to fuel its continued growth and expansion.... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Sonnet BioTherapeutics (NASDAQ:SONN 
Via Benzinga
Biotricity Completes Nasdaq Listing
Closes $15 Million Underwritten Public Offering REDWOOD CITY, CA / ACCESSWIRE / August 30, 2021 / Biotricity, Inc. (NASDAQ: BTCY), a medical diagnostic and consumer... 
Via Benzinga
Biotricity Completes Nasdaq Listing
Closes $15 Million Underwritten Public Offering REDWOOD CITY, CA / ACCESSWIRE / August 30, 2021 / Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today... 
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In A Light Week
Biopharma stocks had a strong start to the week amid optimism generated by full approval accorded to the mRNA vaccine developed by Pfizer, Inc. and BioNTech SE. The stocks subsequently moved back and... 
Via Talk Markets
The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week
Biopharma stocks had a strong start to the week amid optimism generated by full approval accorded to the mRNA vaccine developed by Pfizer, Inc. (NYSE: PFE) and BioNTech SE (... 
Via Benzinga
Biotricity Prices $15 Million Underwritten Public Offering of Common Stock and Listing on the Nasdaq Capital Market
REDWOOD CITY, CA / ACCESSWIRE / August 26, 2021 / Biotricity, Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced... 
Via Benzinga
Who is Dr. Waqaas Al-Siddiq, and Why are His Wearables the Most Crucial Devices MedTech Has Ever Seen?
Biotricity Inc. (NASDAQ: BTCY) is a medtech startup that has seen quarter-over-quarter (QoQ) growth since its inception within the cardiac arena, and just listed on the NASDAQ as... 
Via Benzinga
Biotricity Prices $15 Million Underwritten Public Offering of Common Stock and Listing on the Nasdaq Capital Market
REDWOOD CITY, CA / ACCESSWIRE / August 26, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the pricing of an underwritten public... 
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures COVID-19
Biotricity Announces Proposed Underwritten Public Offering of Common Stock in Connection with Expected Nasdaq Listing
REDWOOD CITY, CA / ACCESSWIRE / August 25, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it intends to offer shares of its... 
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Biotricity Reports 290% Revenue Growth Year Over Year in Record First Quarter
REDWOOD CITY, CA / ACCESSWIRE / August 16, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, is pleased to provide financial results for its fiscal... 
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Product Safety Regulatory
Biotricity to Report First Quarter Fiscal 2022 Financial Results on August 16, 2021
REDWOOD CITY, CA / ACCESSWIRE / August 12, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will release its financial... 
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Innovative Company Biotricity is Providing Solutions for Chronic Diseases
A new study revealed that 44% of older millennials that will soon hit 40 suffer at least one chronic health condition that takes a toll, both financially and emotionally —... 
Via Benzinga
Healthy Hearts and Healthy Wallets: Why one Healthtech Startup is a Must-Invest
Last month, we saw a lot of great startups at the Benzinga Global Small Cap Conference. Many of them screamed, “This is an innovation tech stock you need to buy now!... 
Via Benzinga
Biotricity's 2021 Fiscal Fourth Quarter Growth Trend Continues into Fiscal 2022
Fiscal Q1-22 to be the 9th quarter of growth and biggest quarter to date REDWOOD CITY, CA / ACCESSWIRE / July 7, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare... 
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Why A Northstar Analyst Is Bullish On This Disruptive MedTech Company
A strong value proposition and high retention rate have turned Northland Capital Markets bullish on Biotricity, Inc (OTC: 
Via Benzinga
Biotricity Reports Record Quarterly and Annual Revenue for Fiscal 2021
REDWOOD CITY, CA / ACCESSWIRE / June 15, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, is pleased to provide unaudited, preliminary financial... 
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.